Background Previous studies have suggested a potential risk of cervical cancer in patients
with systemic inflammatory diseases (SID) such as inflammatory bowel disease (IBD) and …

Background & Aims We examined the risk of cervical neoplasia (dysplasia or cancer) in
women with ulcerative colitis (UC) or Crohn's disease (CD). We also calculated the reverse …

Background: Cervical cancer (CC) is still the second in prevalence and mortality among
women. In spite of previously observed higher incidence of cervical dysplasia among …

Background Immunosuppression is a mainstay of therapy for both induction and
maintenance of remission for inflammatory bowel disease (IBD). Women who are chronically …

Objective. The aim was to examine the risk of cervical neoplasia in women with SLE, overall
and with respect to treatment, compared with women from the general population. Methods …

Background Cervical cancer risk is high among immune suppressed women. Aim To
evaluate inflammatory bowel disease (IBD) with medications and risk of cervical cancer …

BACKGROUND & AIMS: We evaluated the risk of cervical abnormalities in women with
inflammatory bowel disease (IBD) in a population-based, nested, case-control study …

Objectives To examine screening patterns and the risk of cervical neoplasia in women with
rheumatoid arthritis (RA) treated or not with tumour necrosis factor inhibitors (TNFi). Methods …

Conflicting data have been published regarding the risk of cervical lesions among women
with systemic lupus erythematosus (SLE). We systematically reviewed the evidence for an …

Background It has been variously reported that women with inflammatory bowel disease
(IBD) have an increased risk of cervical dysplasia. We aimed to assess in a large, accurately …